NCT05537025 - Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis | Biotech Hunter

Enrollment

105

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

September 5, 2025

Study Completion Date

September 5, 2025

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG

ARO-MMP7 Inhalation Solution

ARO-MMP7 by inhalation of nebulized solution

DRUG

Placebo

Calculated volume of normal saline (0.9% NaCl) to match active treatment by inhalation of nebulized solution

Trial Locations (19)

1010

Research Site 1, Auckland

20122

Research Site 3, Milan

Research Site 4, Milan

20123

Research Site 5, Milan

21565

Research Site 3, Soeul

33011

Research Site 2, Oviedo

39008

Research Site 3, Santander

44033

Research Site 1, Ulsan

50134

Research Site 2, Florence

60126

Research Site 1, Ancona

DA-2100

Research Site 1, Copenhagen

DK-5000

Research Site 2, Odense

08011

Research Site 2, Christchurch

05505

Research Site 2, Seoul

08017

Research Site 1, Barcelona

B15 2GW

Research Site 1, Birmingham

EH16 4SA

Research Site 2, Edinburgh

M23 9QZ

Research Site 4, Manchester

M8 5RB

Research Site 3, Manchester